Coeptis Therapeutics Holdings, Inc. received a compliance notice from Nasdaq on January 12, 2026, for not holding an annual shareholder meeting within the required timeframe. The company has 45 days to submit a compliance plan, and is set to hold the meeting on January 30, 2026.